Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Shares Up 5.5 Percent on Breast Cancer Metastasis Findings

NEW YORK, May 23 (GenomeWeb News) - Shares in Sequenom were up more than 5.5 percent at $.95 in afternoon trading today after the company said its scientists have identified a link between the intracellular adhesion molecule gene ICAM1 and breast cancer metastasis.

 

According to Sequenom, the researchers found that the level of ICAM1 protein expression in the cell surface positively correlates with metastatic potential of several human breast cancer cell lines, and that ICAM1 mRNA levels were elevated in breast cancer tumor tissue versus normal tissue.

 

The researchers also found that ICAM1 down-regulation at the mRNA and protein level led to a strong suppression of human breast cell invasion, the company said.

 

The findings were published in today's issue of Carcinogenesis.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.